Home226950 • KOSDAQ
add
OliX Pharmaceuticals Inc
Previous close
₩184,300.00
Day range
₩182,800.00 - ₩191,300.00
Year range
₩34,500.00 - ₩217,000.00
Market cap
3.81T KRW
Avg Volume
409.06K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 4.53B | 9,920.28% |
Operating expense | 12.89B | 69.81% |
Net income | 15.39B | 226.55% |
Net profit margin | 339.73 | 101.26% |
Earnings per share | — | — |
EBITDA | -7.86B | -13.08% |
Effective tax rate | 0.82% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 132.51B | 967.42% |
Total assets | 195.37B | 174.20% |
Total liabilities | 45.29B | -14.19% |
Total equity | 150.08B | — |
Shares outstanding | 20.20M | — |
Price to book | 25.08 | — |
Return on assets | -11.07% | — |
Return on capital | -12.47% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 15.39B | 226.55% |
Cash from operations | -12.16B | -49.12% |
Cash from investing | 1.01B | -74.09% |
Cash from financing | 751.02M | -83.90% |
Net change in cash | -10.92B | -1,432.91% |
Free cash flow | -6.48B | 47.27% |
About
CEO
Founded
2010
Website
Employees
66
